DNA Vaccines (Development)

Collaborative Study Using INJEX Needle-Free Injection System Announced

Published in Vaccine Weekly, February 9th, 2000

Equidyne Corporation announced that its partially-owned Germany based subsidiary, Rosch AG Medizintechnik (Rosch AG), has entered into a collaboration with Bernhard-Nocht-Institute for Tropical Medicine to study subcutaneous delivery of DNA vaccines using the INJEX needle-free injection system.

The Bernhard-Nocht-Institute, based in Hamburg, Germany, and affiliated with the University of Hamburg, is conducting studies to evaluate the efficacy of combining their novel formulations of DNA vaccines with the INJEX needle-free injection system.

DNA-based immunizations may become an attractive alternative to traditional vaccines in the future. Instead of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-02-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry